Back to search
FDAFDA · Food and drugs·Recall number D-1135-2017

Doctor Manzanilla Allergy & Decongestant Relief (diphenhydramine hydrochloride and phenylephrine hydrochloride) Syrup, 12.5 mg and 5 mg in each 5 mL, 4 fl oz. (118 mL) bottle, Distributed by: Midvalley Pharmaceuticals, Raymondville, TX 78580, UPC 7 62558 00204 1.

Published September 20, 2017 · Recall initiated: August 30, 2017

Summary

FDA records drug Class II recall D-1135-2017, published September 20, 2017 and initiated August 30, 2017. Recalling firm: Mid Valley Pharmaceutical; Status: Terminated; Reported quantity: 24 bottles; Lot: Lot: 23221701, Exp. 05/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mid Valley Pharmaceutical
Distributor
TX
Lot
Lot: 23221701, Exp. 05/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doctor Manzanilla Allergy & Decongestant Relief (diphenhydramine hydrochloride and phenylephrine hydrochloride) Syrup, 12.5 mg and 5 mg in each 5 mL, 4 fl oz. (118 mL) bottle, Distributed by: Midvalley Pharmaceuticals, Raymondville, TX 78580, UPC 7 62558 00204 1. recalled?

Yes. FDA published recall D-1135-2017 on September 20, 2017. Reported hazard: CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release